Filter
3074
Filtered Results: 3074
Text search:
sensitivity
Featured
Recommendations
325
New Publications
754
Language
Document type
No document type
1737
Guidelines
470
Studies & Reports
438
Manuals
181
Strategic & Response Plan
86
Fact sheets
64
Training Material
54
Situation Updates
16
Brochures
10
Resource Platforms
10
Infographics
5
Dashboards/Maps
1
App
1
Online Courses
1
Countries / Regions
India
170
Global
123
South Africa
72
Kenya
70
Western and Central Europe
68
Ethiopia
58
Nepal
55
Myanmar / Burma
53
Nigeria
50
Germany
45
Africa
44
Syria
42
Bangladesh
42
Sierra Leone
40
Uganda
40
Indonesia
39
Zambia
38
Tanzania
37
Liberia
37
Latin America and the Carribbean
32
Rwanda
31
Philippines
28
Ghana
27
Malawi
27
Congo, Democratic Republic of
27
Ukraine
24
West and Central Africa
24
Namibia
24
Eastern Europe
22
South–East Asia Region
20
East and Southern Africa
19
South Sudan
19
Lesotho
17
Zimbabwe
17
Mozambique
17
Brazil
17
Russia
15
Cambodia
14
Guinea
12
Jordan
12
Afghanistan
11
Middle East and North Africa
11
Botswana
11
Pakistan
11
Colombia
10
Lebanon
10
Senegal
9
Asia
9
USA
8
Burkina Faso
7
Haiti
7
Venezuela
7
Sudan
7
Yemen
7
Thailand
6
Cameroon
6
Peru
6
Argentina
6
Iraq
6
Tajikistan
5
Iran
5
Western Pacific Region
5
Vietnam
5
Sri Lanka
5
Egypt
5
Somalia
5
Turkey
4
China
4
Eastern Europe and Central Asia
4
Portugal
4
Eswatini/ Swaziland
4
North Macedonia
3
Chile
3
Canada
3
Kyrgyzstan
3
Jamaica
3
Bolivia
3
Mali
3
Angola
3
Madagascar
3
Timor Leste/ East Timor
2
Benin
2
Kazakhstan
2
Burundi
2
Morocco
2
Italy
2
Armenia
2
Saudi Arabia
2
North America
2
Spain
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Moldova
2
Palestine
2
Georgia
2
Central African Republic
2
Chad
2
Libya
2
Ecuador
2
Switzerland
1
Mexico
1
El Salvador
1
Serbia
1
Gambia
1
Albania
1
Laos
1
Estonia
1
Mongolia
1
Qatar
1
Dominican Republic
1
Croatia
1
Hungary
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Japan
1
France
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Azerbaijan
1
Bosnia and Herzegovina
1
Latvia
1
Papua New Guinea
1
Djibouti
1
Greece
1
Honduras
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
988
Clinical Guidelines
326
Public Health
174
Women & Child Health
161
Key Resources
116
Pharmacy & Technologies
64
Capacity Building
60
Toolboxes
Mental Health
269
TB
241
HIV
221
COVID-19
210
Planetary Health
121
NTDs
121
Rapid Response
108
AMR
104
Caregiver
89
Conflict
79
Disability
77
Refugee
75
NCDs
65
Ebola
62
Global Health Education
40
Pharmacy
35
Natural Hazards
33
Polio
30
Cholera
29
Social Ethics
27
Specific Hazards
23
Zika
20
Health Financing Toolbox
19
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Revised and expanded version of the Guidelines
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Climate change presents the single biggest threat to human development, and its widespread impacts disproportionately burden the poorest and most vulnerable households in fragile and rural developing contexts – particularly women and children.
According to the Intergovernmental Panel on Climate C...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
